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We examined the hypothesis that myeloperoxidase 
(MPO), a plentiful constituent ofneutrophils, might seve 
as a marker for tissue neutrophil content. To completely 
extract MPO from either neutrophils or skin, hexadecyl-
trimethylam.monium bromide (HTAB) was used to solu-
bilize the enzyme. With this detergent treatment, 97.8 ± 
0.2% of total recoverable MPO was extracted from neu-
trophils with a single HTAB treatment; 93.1 ± 1.0% was 
solubilized with a single treatment of skin. Neutrophil 
MPO was directly related to neutrophil number; with 
the dianisidine-H202 assay as few as 104 neutrophils 
could be detected. The background level of MPO within 
uninflamed tissue was 0.385 ± 0.018 units per gram of 
tissue, equivalent to only 7.64 ± 0.36 X 105 neutrophils. 
In experimental staphylococcal infection, skin speci-
mens contained 34.8 ± 3.8 units MPO per gram, equiva-
lent to 8.55 ± 0.93 X 107 neutrophils. These studies dem-
onstrate that MPO can be used as a marker for skin 
neutrophil content: it is recoverable from skin in soluble 
form, and is directly related to neutrophil number. Fur-
ther, normal skin possesses a low background of MPO 
compared to that of inflamed skin. 
The accumulation ofneutrophils is a characteristic feature of 
such cutaneous inflammatory diseases as pyogenic infection 
and dermatitis herpetiformis [1]. Indeed, the presence of neu-
trophils in the lesions may bear a relationship to the patho-
physiology of the process. During infection, neutrophils may 
, ingest and kill organisms to reverse the process; in dermatitis 
herpetiformis, neutrophils may accentuate the inflammatory 
process as they secrete their toxic contents [2]. In either case, 
the quantity of neutrophils in skin can be taken as one measure 
of the intensity of the disease process, a nd therefore, a m eans 
of quantifying skin n eutrophil content is of considerable inter-
est. However, the study of skin neutrophil accumulation during 
inflammation has been 'hampei·ed by a lack of the means to 
quantify the total number of neutrophils present in the entire 
t issue lesion. The present study derives from our hypothesis 
that a naturally occurring constituent of neutrophils, myeloper-
oxidase (MPO), might be utilized as a marker for tissue neutro-
phil content. Thus, in this report, we describe a method for 
extracting MPO in soluble form from neutrophils, uninflamed 
skin, a nd skin subjected to infection with staphylococci. Total 
MPO was related to neutrophil number, uninflamed skin pos-
sessed a low background of MPO and bacterially infected skin 
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exhibited an accumulation of MPO. Therefore, we propose that 
the measurement of skin MPO provides a quantitative index of 
tissue neutrophil content. 
MATERIALS AND METHODS 
Preparation of Neutrophils 
Vena cava blood was collected from adult male or female Sprague-
Dawley rats in syringes containing 10-15 units of heparin (Pan heparin, 
Abbott Labs., N. Chicago, IL) per ml of blood. The leukocytes were 
separated in discontinuous gradients of Ficoll (Pharmacia Fine Chem-
icals, Piscataway, NJ) and sodium diatrizoate (Winthrop Lab., NY, 
NY) [3]. Neutrophils thus collected were washed 3 times and suspended 
in McCoy's 5A medium (M5A) (Flow Labs., Inglewood, CA). Contam-
inating erythrocytes were subjected to hypotonic lysis in 3 vol of 
distilled water for 30 seconds, followed by the addition of 1 vol 3.5% 
NaCl. Final cell concentrations were determined by electronic counting 
(Coulter Electronics, Hialeah, FL) . Two hundred cell differential counts 
were performed using Wright's stained smears. The cell suspension 
contained 75 ± 5% (mean ± SEM) neutrophils, 21 ± 5% lymphocytes, 
1.8 ± 0.5% monocytes and 2.4 ± 0.5% eosinophils. 
Preparation of Mononuclear Cells 
Monocyte-lymphocyte suspensions were obtained from heparinized 
rat blood by ficoll-sodium diatrizoate (Ficoll-Paque, Pharmacia) sepa-
ration [ 4). The resulting monocyte-lymphocyte suspensions contained 
17 ± 1% monocytes and 83 ± 1% lympt)ocytes and were free from 
contaminating neutrophils. 
Bacteria 
Staphylococcus aureus ATCC#25923 were grown overnight in tryp -
tic soy broth (Difco Lab., Detroit, Ml) and were washed and suspended 
in M5A prior to use. The concentration of bacteria was determined by 
McFarland standards (5]. 
Myeloperoxidase Assay 
Myeloperoxidase was extracted from cells or homogenized tissue by 
suspending the material in 0.5% hexadecyltrimethylammonium bro-
mide (HTAB) (Sigma Chemical Co., St. Louis, MO) in 50 mM potassium 
phosphate buffer, pH 6.0, before sonication in an ice bath for 10 seconds 
(Heat Systems-Ultrasonics, P lainview, NY) . The specimens were 
freeze-thawed 3 times, after which sonication was repeated. Suspen-
sions were then centrifuged at 40,000 Xg for 15 min and the resulting 
supernate or pellet assayed. 
MPO was assayed spectrophotometrically: 0.1 ml of the material to 
be measw-ed was mixed with 2.9 ml of 50 mM phosphate buffer, pH 6.0, 
containing 0.167 mg/ml o-dianisidine dihydTochloride (Sigma Chemical 
Co.) and 0.0005% hydrogen peroxide (Mallinckrodt, Paris, KY) . These 
conditions were employed because they confer increased sensitivity to 
the assay [6]. The change in absorbance at 460 nm was measmed with 
a Beckman DU spectrophotometer (Beckman Instruments, Fullerton, 
CA) with a recording attachment (Gilford Instrument Labs., Oberlin, 
OH). Turbid suspensions were assayed in the photomultiplier com-
partment of a Cary Spectrophotometer Model 118 (Varian, Palo Alto, 
CA) . One unit of MPO activity was defined as that degrading one 
micromole of peroxide per minute at 25°C [7]. 
Statistical Analysis 
Data were analyzed by means of Student's t-test. 
RESULTS 
Extraction of Neutrophil Myeloperoxidase (MPO) Activity 
Since MPO is located within the primary granules of neutro-
phils [8], extraction of MPO depends upon procedures to dis-
rupt the granules, as well as ones which render MPO soluble in 
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aqueous solution. To evaluate the recovery of neutrophil MPO 
in soluble form, 0.57 to 4.10 X 106 neutrophils were subjected to 
sonication and freeze-thawing in 2 ml 50 mM phosphate buffer 
pH 6.0 or 2 ml 50 mM phosphate buffer containing 0.5% HT AB. 
The suspensions were centrifuged at 40,000 xg for 15 min and 
the MPO activity in the supernate or in the pellet assayed. As 
shown in Fig 1, when the cells were disrupted in buffer alone, 
most of the activity remained associated with the particles. In 
contrast, when neutrophils were disrupted in HT AB, recovery 
of activity was enhanced and virtually all the activity appeared 
in the supernate. The pellets from the HTAB-treated cells were 
extracted with 2 ml HTAB, and the extracts and the pellets 
assayed. The initial extract contained 97.8 ± 0.2% of the total 
recoverable activity. After 3 extractions, no additional MPO 
was obtained in soluble form and 1.4 ± 0.4% of the activity 
remained in the pellet. 
Determination of MPO Per Neutrophil 
To determine neutrophil MPO content, neutrophils were 
obtained from caval blood from adult rats, and the cellular 
MPO was extracted with 0.5% HT AB. In 12 experiments, the 
MPO recovered from 0.75-4.02 X 106 neutrophils was 5.04 ± 
0.21 x 10- 7 U per neutrophil and was proportional to the 
number of neutrophils subjected to extraction. The sensitivity 
of the method permitted MPO extraction from as few as 0.035 
x 106 neutrophils (Fig 2) . 
MPO Activity of Uninflamed Shin 
To determine the background levels of peroxidase in control 
unirrflamed skin, circular full thickness specimens of skin 15 
rnm diameter were excised from the shaved dorsum of rats. The 
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FIG 1. Effect of hexadecyltrimethylammonium bromide (HTAB) 
upon MPO recovery. MPO recovered from either the supernate or 
pellet fraction of disrupted neutrophils is shown. The bars represent 
the mean values and the brae/lets indicate standard error for groups of 
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FIG 2. Relationship of recovered MPO activity to neu trophil num-
ber. Each point represents a single value for MPO recovered from 
specimens containing various numbers of blood neutrophils. 
1 ml 0.5% HTAB in 50 mM phosphate buffer pH 6.0. The 
suspension was transferred to a Potter-Elvejhem type homog-
enizer, and the beaker was rinsed twice with 1 ml HTAB, the 
rinses being added to the homogenizer. The suspension was 
homogenized for 10 min in ice bath by means of a Teflon 
plunger powered by a variable speed drill (Black & Decker Mfg. 
Co., Towson, MD). The homogenizer was rinsed twice with 1 
ml HT AB and the pooled homogenate (5 ml) was subjected to 
sonication and freeze-thawing. The suspension was centrifuged 
at 40,000 xg for 15 min and the supernate reserved. The 
homogenized tissue pellet was extracted 4 times with 5 ml 
HT AB, and the extracts and pellet assayed. In six experiments, 
the first plus second extracts contained 81.7 ± 0.9% of the total 
recoverable activity. After 4 extractions of the pellet, no addi-
tional MPO activity could be extracted and the residual pellet 
exhibited 9.8 ± 0.9% of the total recoverable activity (soluble 
plus particle associated). The skin specimens, which weighed 
0.2900 ± 0.0045 gm, contained 0.114 ± 0.005 U peroxidase per 
specimen, or 0.385 ± 0.018 U per gram wet tissue. Based upon 
5.04 x 10- 7 U MPO per neutrophil, the peroxidase activity 
recoverable from n01mal skin was equivalent to 7.64 ± 0.36 X 
105 neutrophils per gram of tissue, or 2.26 ± 0.10 X 105 neutro-
phils per skin specimen. 
To determine whether skin tissue might interfere with the 
recovery of neutrophil MPO in inflammatory lesions, neutro-
phils were combined with specimens of uninflamed skin, and 
the MPO content of the neutrophils plus skin was compared to 
that of an aliquot containing the same number of neutrophils 
alone. In 10 experiments, skin plus 0.61 to 3.68 X 106 neutrophils 
was homonogenized in 0.5% HT AB after which the specimens 
were subjected to sonication and freeze-thawing. The MPO 
activity recovered in the initial extract from skin plus neutro-
phils ranged from 0.233 to 2.007 U MPO and was 97 ± 3% of 
that obtained from neutrophils alone, indicating that skin did 
not itself interfere with MPO recovery. 
MPO Assay in Cutaneous Inflammatory Lesions 
In order to induce experimental cutaneous inflammation, rats 
received 1.3-2.5 x 109 staphylococci (5 x 1010 organisms per ml) 
by intradermal injection into the skin of the dorsum. Two such 
injections were given to each animal and resulted in erythema 
and swelling at the injection sites. Twenty-four hours after 
inoculation, the animals were phlebotomized and sacrificed, 
and the inflammatory lesions were excised. The lesions were 
minced in medium and the inflammatory suspension collected 
to determine its composition. The inflammatory cells shed 
during mincing were 90.8 ± 0.9% neutrophils, 3.1 ± 0.5% mono-
cytes, 0.2 ± 0.1% lymphocytes, and 5.8 ± 0.7% damaged nu-
cleated cells. The minced tissue was suspended in 3.0 ml 0.5% 
HT AB and subjected to MPO extraction by homogenization in 
a Potter-Elvejhem homogenizer as described above. The sus-
208 BRADLEY ET AL 
Recovery of myeloperoxidase activity from inflamed skin: Mean 
values (±SE) are given for units of myeloperoxidase and percent of 







16.00 ± 2.98 
0.88 ± 0.29 
0.09 ± 0.06 
0.24 ± 0.02 
17.21 ± 3.27 
%Total Activity 
93.1 ± 1.0 
4.9 ± 0.8 
0.4 ± 0.2 
1.6 ± 0.3 
100.0 ± 19.0 
pension was removed and the homogenizer washed twice with 
1 ml HT AB, the washes being added to the suspension. Then 
the suspension was centrifuged at 40,000 Xg for 15 min and the 
supernate reserved . The pellet was extracted 10 additional 
times with 5 ml HT AB, and the extracts and pellet assayed. 
The result of 5 such experiments, shown in the Table, demon-
strates that direct extraction of inflamed tissue yielded 98.0 ± 
0.3% of the activity in soluble form, the remainder being asso-
ciated with the tissue pellet. Of the total recoverable activity, 
17.21 ± 3.27 U per specimen, 93.1 ± 1.0% was contained in the 
initial extract. By means of the blood neutrophil content, 4.07 
± 0.20 x 10- 7 U per neutrophil in the infected animals, the 
MPO from inflamed skin was found to be equivalent to 4.23 ± 
0.80 X 107 neutrophils per specimen. 
Nonneutrophil Contribution to Lesion Peroxidase Content 
The possibility that monocyte peroxidase activity might con-
tribute to the inflammatory lesion MPO content was also 
evaluated . Since monocytes are granulocytes which also possess 
MPO activity [9], their MPO content was evaluated in blood 
monocyte-lymphocyte suspensions. In 4 such specimens, 0.67-
1.40 x 106 monocytes contained 9.36 ± 2.20 X 10_,, U MPO per 
monocyte . Thus, the level ofMPO activity in monocytes (which 
comprised only 3.1 ± 0.5% of the inflammatory cells) could 
account for only 0.06 ± 0.01% of the MPO recovered from 24 hr 
inflammatory lesions. Although eosinophils contain peroxidase, 
no eosinophils appeared in the lesions and thus did not contrib-
ute activity .. S. aureus (5 X 10\\)) had no detectable peroxidase 
activity. 
DISCUSSION 
Accumulation of neutrophils is a prominent feature of a 
number of inflammatory diseases of the skin [1, 10-12]. Indeed, 
an ability to estimate the quantity of neutrophils in inflamed 
tissue might prove useful to judge the intensity of inflammation 
or the effect of experimental or therapeutic maneuvers to alter 
the inflammatory response. Furthermore, a means to quantify 
tissue neutrophil content might be useful in exploring factors 
which influence neutrophil migration to skin in vivo. We rea-
soned that MPO, a constituent of neutrophils, would be a 
marker for tissue neutrophils, since the enzyme is abundant in 
neutrophils comprising as much as 5% of their mass [8]. How-
ever, MPO is tightly associated with the cell granules as noted 
by Patriarca, Cramer et al [13] and as demostrated by the 
present cell disruption studies. When cells were disrupted in 
aqueous buffer alone, 71% of the MPO activity remained asso-
ciated with the particulate fraction of the cells, and only trace 
amounts were found in the supernate. In contrast, treatment 
with HTAB, an ionic detergent previously shown to solubilize 
MPO [13, 14, 15, 16] resulted in extraction of 99% of the MPO 
to ·the soluble fraction of disrupted cells, with enhanced recov-
ery of activity as well. HT AB extraction of neutrophils in the 
presence of skin was effective in recovering 97% of the added 
activity, indicating that soluble extraction of MPO from neutro-
phils which had accumulated in inflamed skin would be possi-
ble. Subsequent experiments to study neutrophil accumulation 
in bacterially infected skin revealed that HT AB treatment 
permitted 93% of the recoverable activity to appear in the first 
extract. Inflammatory cells shed from the lesion during mincing 
were primarily neutrophils (91 %) with relatively small numbers 
Vol. 78, No.3 
of monocytes, which contributed only 0.06% of the total lesion 
MPO. Thus, in these lesions, MPO content was taken as a 
reflection of the quantity of neutrophils which had migrated 
there during the infection. By comparing the total lesion MPO 
with the average blood neutrophil MPO from the same animal, 
it was possible to calculate a minimum number of neutrophils 
which must have migrated to the lesion to contribute the MPO 
therein. 
Although the number of neutrophils in inflamed skin may be 
estimated by the MPO method, the calculation of the neutro-
phil number warrants further discussion. First, quantification 
of tissue neutrophil content is necessarily a rrieasure of the net 
accumulation of the cells or their markers. Thus, it might be 
expected that due to neutrophil or MPO loss, any measm·ement 
would be a minimum estimate of neutrophil accumulation in 
the lesion, and might underestimate the total number of neu-
trophils which had migrated there prior to assay. Also, neutro-
phils stimulated by the ingestion of staphylococci may contain 
less MPO than do resting neutrophils [17]. For this reason, 
interepretation must be tempered by the concept that tissue 
MPO levels reflect the minimum number of blood neutrophils 
which must have reached the lesion to contribute their MPO, 
and that the measurement may represent an underestimate of 
the total migration of neutrophils to the lesion before sampling. 
From the data, we conclude that MPO is a marker for tissue 
neutrophil content: MPO was extractable in soluble form by 
HT AB, whether from neutrophils alone or from neutrophils in 
the presence of skin. Further, MPO bore a direct relationship 
to the number of cells from which it was extracted. Control 
uninflamed skin possessed a low background of MPO, but when 
neutrophils accumulated in bacterially infected skin, the skin 
MPO increased one hundred fold and could be recovered in 
soluble form by HTAB treatment. We propose that skin MPO 
content may be useful as a measure of the neutrophil inflam-
matory response in a variety of clinical and experimental states. 
Of course, use of this approach in humans depends upon ad-
aptation of the technique specifically· for human cells and skin. 
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